Evidence map›Paper›PMID 33402955›Full record

ArticleAfrican health sciences2020

Vancomycin intermediate resistant

Morenike Adeoye-Isijola, Olufunmiso Olajuyigbe, Kehinde Adebola, Roger Coopoosamy, Anthony Afolayan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Twenty years ofAfrican health sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Morenike Adeoye-IsijolaDepartment of Microbiology, School of Science & Technology, Babcock University, PMB 4005, Ilisan-Remo, Ogun State, Nigeria.
Olufunmiso OlajuyigbeDepartment of Microbiology, School of Science & Technology, Babcock University, PMB 4005, Ilisan-Remo, Ogun State, Nigeria.
Kehinde AdebolaDepartment of Public Health, Babcock University, Ilisan Remo, Ogun State, Nigeria.
Roger CoopoosamyDepartment of Nature Conservation, Faculty of Natural Sciences, Mangosuthu University of Technology, P.O. Box 12363, Jacobs, 4026, Durban, Kwa-Zulu Natal, South Africa.
Anthony AfolayanMedicinal Plants and Economic Development (MPED) Research Centre, Botany Department, University of Fort Hare, Alice Campus, South Africa.
Babcock University · NGMangosuthu University of Technology · ZAUniversity of Fort Hare · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe potential of transmitting multidrug resistant

methodsThe antibiograms of the

resultsOf the 152

conclusionThe isolation of multi-drug and vancomycin intermediate resistant strains of

Indexed as

Anti-Bacterial AgentsCarrier StateHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsNasal CavityStaphylococcus aureusVancomycinVancomycin-Resistant Staphylococcus aureusAnti-Bacterial AgentsVancomycinAntibacterial activitymultidrug resistancevancomycinVISAVRSA

Identifiers

PMID33402955
PMCPMC7751515
OpenAlexW3092283143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.